Skip to content

Clinical trials

Phase 1/2 Lymphoma, Non-Hodgkin trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1/2 Country / region: Australia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20121
20131
20152
20163
20171
20181
20194
20213
20223
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10
Completed9
Recruiting7
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
AstraZeneca2
Bristol-Myers Squibb2
CRISPR Therapeutics AG2
Merck Sharp & Dohme LLC2
Accenture1
BeOne Medicines1
Epizyme, Inc.1
Genentech, Inc.1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin29
Lymphoma, Follicular9
Lymphoma, B-Cell8
Lymphoma, Large B-Cell, Diffuse7
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma6
Hodgkin Disease5
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Mantle-Cell4
Recurrence4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.